Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.
Tohru YoneyamaHayato YamamotoMihoko Sutoh YoneyamaYuki TobisawaShingo HatakeyamaTakuma NaritaHirotake KodamaMasaki MomotaHiroyuki ItoShintaro NaritaFumiyasu TsushimaKoji MitsuzukaTakahiro YoneyamaYasuhiro HashimotoWilhelmina C M DuivenvoordenJehonathan H PinthusShingo KakedaAkihiro ItoNorihiko TsuchiyaTomonori HabuchiChikara OhyamaPublished in: The Prostate (2021)
The diagnostic performance of S23PSAD was superior to conventional strategies but comparable to mpMRI.